FMO5 and chronic granulomatous disease: For instance, children may develop manifestations of inflammatory bowel disease (IBD) with neutrophilic inflammation due to primary genetic defects in the innate immune system, including chronic granulomatous disease (CGD) with mutations in NADPH oxidase (39).